共 43 条
[1]
Desai M(2007)Epidemiology and burden of malaria in pregnancy Lancet Infect Dis. 7 93-104
[2]
ter Kuile FO(2017)Travel characteristics and pretravel health care among pregnant or breastfeeding US women preparing for international travel Obstet Gynecol 130 1357-1365
[3]
Nosten F(1996)Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand Am J Trop Med Hyg 54 62-66
[4]
McGready R(2007)Atovaquone–proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II) Am J Trop Med Hyg 76 208-223
[5]
Asamoa K(2014)Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment Cochrane Database Syst Rev. 10 CD000169-223
[6]
Brabin B(2007)Toxoplasmosis Semin Fetal Neonatal Med. 12 214-853
[7]
Newman RD(2005)A randomized comparison of artesunate–atovaquone–proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy J Infect Dis 192 846-582
[8]
Hagmann SHF(2005)The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women Eur J Clin Pharmacol 61 573-260
[9]
Rao SR(2011)Atovaquone–proguanil use in early pregnancy and the risk of birth defects Arch Intern Med 171 259-undefined
[10]
LaRocque RC(undefined)undefined undefined undefined undefined-undefined